Stock daily read

What happened with TRNS today?

Why it moved
Explains possible causes using the day’s news and filings
Moving with the market?
Uses market moves and trading volume to assess what drove the change
What to watch next
The next thing that could change the call, and what to look for

No read yet

Uses news and trading volume to explain the day’s move and how it relates to the market.

Investment outlook

TRNS in three months: buy, wait or sell?

Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.

In the report
  • Buy / Wait / Sell rating
  • 3-month target price
  • Bear · Base · Bull
  • vs. the market

Company

Company overview

Transcat helps manufacturers keep test and measurement instruments accurate and meet quality and compliance requirements. Its customers include life sciences and pharmaceutical companies, aerospace and defense businesses, and energy and industrial companies. Services generate most of its revenue: customers pay for instrument calibration, repair and related work, ranging from a single instrument to an entire calibration program. Regular calibration cycles bring repeat business. Work takes place at Transcat’s laboratories or customer sites, and its laboratory accreditation requires measurements to be traceable to documented standards.

The other substantial business sells and rents new and used test, measurement and control instruments. Customers buy equipment to replace or upgrade existing instruments or expand manufacturing and research facilities. Transcat can calibrate instruments before shipment and supply replacements when existing equipment can no longer be calibrated. This business depends on customers’ equipment budgets and manufacturers’ product supply.

Revenue is spread across many customers, with no single customer accounting for a large share. Equipment sourcing is more concentrated: a small group of vendors supplies products representing most Distribution sales, and the largest vendor alone accounts for a substantial share.

Read allShow less
Source: SEC filing

Red flags

Know what’s buried in TRNS’s filings before you buy

The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.

Sorted into
  • Happening now
  • Could go wrong
  • Built in

Moat

TRNS says it has a moat. Does it hold up?

Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.

Each edge rated
  • Strong
  • Moderate
  • Limited
  • Unproven

Related companies

Transcat's results depend on regulated manufacturers' recurring calibration needs, acquisition integration and customers' spending on measurement instruments, rather than the semiconductor-test or construction cycles that drive these candidates.

Agenda

in 8 daysWed, Oct 28

  1. 2:00 PMET

    Fed Interest Rate Decision

    The Fed’s policy rate—the benchmark that influences borrowing costs—can change what Transcat pays on its $99.9 million revolving credit balance and on future borrowing, affecting interest expense and earnings.

in 13 daysMon, Nov 2

  1. Time to be announced
    Major

    Transcat Inc earningsThis company

    Transcat’s report will show whether demand for its calibration services is turning into durable growth, rather than revenue growth driven mainly by acquisitions.